Blackrock, INC Schedule 13G passive stakes
NYSE
BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing a beneficial ownership of 8.3% of CVS Health Corporation's common stock as of June 30, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 11 to its Schedule 13G, disclosing a 6.5% beneficial ownership stake in CarMax Inc. common stock as of June 30, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 6.9% beneficial ownership stake in Arthur J. Gallagher and Co.'s common stock, held for passive investment purposes.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, revealing a 6.8% beneficial ownership stake in SEI Investments Company, totaling 8,492,433 common shares.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, revealing a 5.2% beneficial ownership stake in Taysha Gene Therapies Inc.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 2.4% passive beneficial ownership stake in Tillys Inc.'s Class A Stock.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 6.2% of TRIMAS CORP's common stock as of June 30, 2025.
NYSE
BlackRock, Inc. has filed an amendment to its Schedule 13G, reporting a passive beneficial ownership of 4.8% in Tucows Inc.'s Class A Stock as of June 30, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Amends CIMPRESS PLC Stake to 4.6%
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 4.6% beneficial ownership stake in CIMPRESS PLC's common stock as of June 30, 2025.
NYSE
BlackRock, Inc. has reported a 5.9% beneficial ownership stake in Foreign Trade Bank of Latin America Inc., holding over 1.7 million common shares.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 1.8% Stake in AGENUS INC Common Stock
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 1.8% beneficial ownership stake in AGENUS INC's common stock as of June 30, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 4.8% Passive Stake in AppLovin Corp
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 4.8% beneficial ownership stake in AppLovin Corp's Class A Stock as a passive investor.
NYSE
SCHEDULE 13G/A: BlackRock Amends Schedule 13G, Disclosing 2.0% Passive Stake in Artiva Biotherapeutics
BlackRock, Inc. filed an Amendment No. 1 to its Schedule 13G, reporting a 2.0% passive beneficial ownership stake in Artiva Biotherapeutics, Inc. as of June 30, 2025.
NYSE
BlackRock, Inc. has filed an amendment to its Schedule 13G, reporting a 6.8% beneficial ownership stake in Beyond Meat, Inc. as of June 30, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Reduces Stake in C4 Therapeutics to 2.5%
BlackRock, Inc. has reduced its beneficial ownership in C4 Therapeutics, Inc. to 2.5% of the common stock, as disclosed in an amended Schedule 13G filing.
NYSE
BlackRock, Inc. has filed an Amendment No. 6 to its Schedule 13G, disclosing a 2.1% passive beneficial ownership stake in Cardlytics, Inc. as of June 30, 2025.
NYSE
BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing a 3.2% passive beneficial ownership stake in Cassava Sciences Inc. as of June 30, 2025.
NYSE
BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing a continued beneficial ownership of 8.8% of Chewy, Inc.'s common stock as of June 30, 2025.
NYSE
BlackRock, Inc. has filed an updated Schedule 13G, revealing a 1.3% passive beneficial ownership stake in Clear Channel Outdoor Holdings Inc. as of June 30, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 6.9% Stake in Coinbase Class A Stock
BlackRock, Inc. has filed an amended Schedule 13G, revealing a beneficial ownership of 6.9% of Coinbase Global Inc.'s Class A stock.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 1.8% Passive Stake in Shattuck Labs
BlackRock, Inc. has filed an amended Schedule 13G, reporting a passive beneficial ownership of 1.8% of Shattuck Labs, Inc.'s common stock as of June 30, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 1.6% Passive Stake in SmartRent, Inc.
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 1.6% beneficial ownership stake in SmartRent, Inc.'s common stock as of June 30, 2025.
NYSE
BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing a 2.9% beneficial ownership stake in Stagwell Inc. as of June 30, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 2.8% Passive Stake in Star Holdings
BlackRock, Inc. has filed an amended Schedule 13G, reporting a passive beneficial ownership of 2.8% in Star Holdings' common stock as of June 30, 2025.
NYSE
BlackRock, Inc. has filed an amendment to its Schedule 13G, reporting a passive beneficial ownership of 2.3% in Stoneridge Inc.'s common stock as of June 30, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Reduces Stake in TPI Composites Below 5%
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a beneficial ownership of 1.8% in TPI Composites Inc. common stock.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 1.7% Stake in Tenaya Therapeutics
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 1.7% beneficial ownership stake in Tenaya Therapeutics, Inc. as of June 30, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 7.6% Stake in 10x Genomics
BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 7.6% of the common stock of 10x Genomics, Inc. as of June 30, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 1.9% Passive Stake in Ventyx Biosciences
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 1.9% passive beneficial ownership stake in Ventyx Biosciences, Inc. as of June 30, 2025.
NYSE
BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing a 1.7% beneficial ownership stake in Vera Bradley Inc. as of a future event date of June 30, 2025.